Texas Yale Capital Corp.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1332342
ST. PETERSBURG, FL
Position in REGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,199,690
-$286,869 QoQ
Shares Held
1,924
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#611
of 1,322 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Texas Yale Capital Corp. holds $3,520,339 across 3 Biotechnology names. REGN ranks #2 (34.1% of the industry book) .
All Filings in REGN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,199,690 | 1,924 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,486,559 | 1,924 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,485,077 | 1,924 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,081,807 | 1,924 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,010,100 | 1,924 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,226,600 | 1,934 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,377,646 | 1,934 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,033,098 | 1,934 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,032,692 | 1,934 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,861,455 | 1,934 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,698,612 | 1,934 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,583,375 | 1,924 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,382,470 | 1,924 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,580,893 | 1,924 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,388,146 | 1,924 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,325,385 | 1,924 | Shares | Sole | 2022-11-08 | |
| No filing history on record for this holder in this stock. | ||||||